- Home
- COMM vs CRGX Comparison
COMM vs CRGX Comparison
Compare COMM & CRGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COMM
- CRGX
- Stock Information
- Founded
- COMM 1976
- CRGX 2021
- Country
- COMM United States
- CRGX United States
- Employees
- COMM N/A
- CRGX N/A
- Industry
- COMM Radio And Television Broadcasting And Communications Equipment
- CRGX
- Sector
- COMM Technology
- CRGX
- Exchange
- COMM Nasdaq
- CRGX Nasdaq
- Market Cap
- COMM 1.3B
- CRGX 190.0M
- IPO Year
- COMM 2013
- CRGX 2023
- Fundamental
- Price
- COMM $7.53
- CRGX $4.59
- Analyst Decision
- COMM Hold
- CRGX Hold
- Analyst Count
- COMM 5
- CRGX 7
- Target Price
- COMM $4.88
- CRGX $5.33
- AVG Volume (30 Days)
- COMM 5.8M
- CRGX 1.9M
- Earning Date
- COMM 08-07-2025
- CRGX 08-11-2025
- Dividend Yield
- COMM N/A
- CRGX N/A
- EPS Growth
- COMM N/A
- CRGX N/A
- EPS
- COMM 3.42
- CRGX N/A
- Revenue
- COMM $4,417,100,000.00
- CRGX N/A
- Revenue This Year
- COMM $21.50
- CRGX $57.81
- Revenue Next Year
- COMM $8.30
- CRGX N/A
- P/E Ratio
- COMM $2.21
- CRGX N/A
- Revenue Growth
- COMM 16.19
- CRGX N/A
- 52 Week Low
- COMM $1.32
- CRGX $3.00
- 52 Week High
- COMM $8.67
- CRGX $25.45
- Technical
- Relative Strength Index (RSI)
- COMM 55.72
- CRGX 61.56
- Support Level
- COMM $7.67
- CRGX $4.32
- Resistance Level
- COMM $8.67
- CRGX $4.63
- Average True Range (ATR)
- COMM 0.41
- CRGX 0.16
- MACD
- COMM -0.07
- CRGX 0.04
- Stochastic Oscillator
- COMM 55.29
- CRGX 76.44
About COMM CommScope Holding Company Inc.
CommScope Holding Co Inc is a provider of infrastructure solutions for communication, data center, and entertainment networks. The company provides solutions for wired and wireless networks to enable service providers, including cable, telephone, data center, and digital broadcast satellite operators and media programmers, to deliver media, voice, Internet Protocol (IP) data services, and Wi-Fi to their subscribers and allow enterprises to experience constant wireless and wired connectivity across complex and varied networking environments. The company's operating segments are: Connectivity and Cable Solutions (CCS), Networking, Intelligent Cellular and Security Solutions (NICS), and Access Network Solutions (ANS).
About CRGX CARGO Therapeutics Inc.
Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platforms, and manufacturing are designed to directly address the limitations of approved chimeric antigen receptor (CAR) T-cell therapies. Its product includes CRG-023, an investigational tri-specific CAR T designed to address several known causes of relapse associated with existing CAR T-cell therapies such as loss of tumor antigen expression, loss of co-stimulation (e.g., via CD58/CD2 signaling) and T cell exhaustion. CRG-023 is designed to target the B-cell lineage antigens (CD19, CD20, CD22) via tri-cistronic expression of three distinct CARs from a single lentiviral vector.